199 related articles for article (PubMed ID: 32495964)
1. A Spore-Forming Probiotic Supplement Improves the Intestinal Immune Response and Protects the Intestinal Health During Recurrent Clostridioides difficile Colonization in Mice.
Ramezani Kapourchali F; Glueck B; Han Y; Shapiro D; Fulmer CG; Cresci GAM
JPEN J Parenter Enteral Nutr; 2020 Nov; 44(8):1428-1438. PubMed ID: 32495964
[TBL] [Abstract][Full Text] [Related]
2. Faecalibacterium prausnitzii and a Prebiotic Protect Intestinal Health in a Mouse Model of Antibiotic and Clostridium difficile Exposure.
Roychowdhury S; Cadnum J; Glueck B; Obrenovich M; Donskey C; Cresci GAM
JPEN J Parenter Enteral Nutr; 2018 Sep; 42(7):1156-1167. PubMed ID: 29385239
[TBL] [Abstract][Full Text] [Related]
3. Correlating Antibiotic-Induced Dysbiosis to
Moore JH; Salahi A; Honrado C; Warburton C; Tate S; Warren CA; Swami NS
ACS Infect Dis; 2023 Oct; 9(10):1878-1888. PubMed ID: 37756389
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model.
Yang J; Meng L; Yang H
Microbiol Spectr; 2022 Apr; 10(2):e0067222. PubMed ID: 35311540
[TBL] [Abstract][Full Text] [Related]
5. Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against
Murphy CK; O'Donnell MM; Hegarty JW; Schulz S; Hill C; Ross RP; Rea MC; Farquhar R; Chesnel L
World J Gastrointest Pathophysiol; 2023 Aug; 14(4):71-85. PubMed ID: 37727283
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model.
Chilton CH; Crowther GS; Miossec C; de Gunzburg J; Andremont A; Wilcox MH
J Antimicrob Chemother; 2020 Jun; 75(6):1458-1465. PubMed ID: 32097465
[TBL] [Abstract][Full Text] [Related]
7. Protection from Lethal Clostridioides difficile Infection via Intraspecies Competition for Cogerminant.
Leslie JL; Jenior ML; Vendrov KC; Standke AK; Barron MR; O'Brien TJ; Unverdorben L; Thaprawat P; Bergin IL; Schloss PD; Young VB
mBio; 2021 Mar; 12(2):. PubMed ID: 33785619
[No Abstract] [Full Text] [Related]
8. Quantifying bacterial spore germination by single-cell impedance cytometry for assessment of host microbiota susceptibility to Clostridioides difficile infection.
Moore JH; Salahi A; Honrado C; Warburton C; Warren CA; Swami NS
Biosens Bioelectron; 2020 Oct; 166():112440. PubMed ID: 32745926
[TBL] [Abstract][Full Text] [Related]
9. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
[TBL] [Abstract][Full Text] [Related]
10. A probiotic yeast-based immunotherapy against
Chen K; Zhu Y; Zhang Y; Hamza T; Yu H; Saint Fleur A; Galen J; Yang Z; Feng H
Sci Transl Med; 2020 Oct; 12(567):. PubMed ID: 33115949
[TBL] [Abstract][Full Text] [Related]
11. The natural product chlorotonil A preserves colonization resistance and prevents relapsing Clostridioides difficile infection.
Bublitz A; Brauer M; Wagner S; Hofer W; Müsken M; Deschner F; Lesker TR; Neumann-Schaal M; Paul LS; Nübel U; Bartel J; Kany AM; Zühlke D; Bernecker S; Jansen R; Sievers S; Riedel K; Herrmann J; Müller R; Fuchs TM; Strowig T
Cell Host Microbe; 2023 May; 31(5):734-750.e8. PubMed ID: 37098342
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.
van Opstal E; Kolling GL; Moore JH; Coquery CM; Wade NS; Loo WM; Bolick DT; Shin JH; Erickson LD; Warren CA
J Infect Dis; 2016 Jul; 214(1):130-9. PubMed ID: 26917573
[TBL] [Abstract][Full Text] [Related]
13. The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation.
Lopez CA; Beavers WN; Weiss A; Knippel RJ; Zackular JP; Chazin W; Skaar EP
mBio; 2019 Nov; 10(6):. PubMed ID: 31744916
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Gut Microbiota and Host Immunity with a
Shapiro D; Kapourchali FR; Santilli A; Han Y; Cresci GAM
Microorganisms; 2022 Jun; 10(6):. PubMed ID: 35744696
[TBL] [Abstract][Full Text] [Related]
15. Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
Ajami NJ; Cope JL; Wong MC; Petrosino JF; Chesnel L
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463537
[No Abstract] [Full Text] [Related]
16. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.
Gebhart D; Lok S; Clare S; Tomas M; Stares M; Scholl D; Donskey CJ; Lawley TD; Govoni GR
mBio; 2015 Mar; 6(2):. PubMed ID: 25805733
[TBL] [Abstract][Full Text] [Related]
17. Nasal Immunization with the C-Terminal Domain of Bcla3 Induced Specific IgG Production and Attenuated Disease Symptoms in Mice Infected with
Maia AR; Reyes-Ramírez R; Pizarro-Guajardo M; Saggese A; Ricca E; Baccigalupi L; Paredes-Sabja D
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933117
[No Abstract] [Full Text] [Related]
18. A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.
Rätsep M; Kõljalg S; Sepp E; Smidt I; Truusalu K; Songisepp E; Stsepetova J; Naaber P; Mikelsaar RH; Mikelsaar M
Anaerobe; 2017 Oct; 47():94-103. PubMed ID: 28465256
[TBL] [Abstract][Full Text] [Related]
19. Pulsed dosing and extended daily dosing of oral vancomycin do not facilitate clearance of
Pearlmutter BS; Carlisle MG; Wilson BM; Sangwan N; Donskey CJ
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0090323. PubMed ID: 38095427
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy.
Maziade PJ; Ship N; Sniffen JC; Goldstein EJC
Clin Infect Dis; 2021 Oct; 73(8):1524-1527. PubMed ID: 33966076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
